Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tim Heiland
Observed name:
Heiland, Tim
Institution:
University Hospital Ulm
Observed institutions:
NewYork–Presbyterian Hospital,
Universität Ulm,
University Hospital Ulm
OpenAlex ID:
A5014207050
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3
2021
·
Marc-Eric Halatsch
, Richard E Kast
, et al.
·
Neuro-Oncology Advances
·
89
Ten-Step Minimally Invasive Spine Lumbar Decompression and Dural Repair Through Tubular Retractors
2017
·
Mohamed Abdelatif Boukebir
, Connor David Berlin
, et al.
·
Operative Neurosurgery
·
85
Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin
2017
·
Richard E Kast
, Quentin A Hill
, et al.
·
Tumor Biology
·
74
A New Experimental Polytrauma Model in Rats: Molecular Characterization of the Early Inflammatory Response
2012
·
Sebastian Weckbach
, Mario Perl
, et al.
·
Mediators of Inflammation
·
49
PDF
Bcl‐2/Bcl‐xL inhibition predominantly synergistically enhances the anti‐neoplastic activity of a low‐dose CUSP9 repurposed drug regime against glioblastoma
2019
·
Marc‐Eric Halatsch
, Richard Eric Kast
, et al.
·
British Journal of Pharmacology
·
30
In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma
2021
·
Marc-Eric Halatsch
, Annika Dwucet
, et al.
·
Pharmaceuticals
·
28
PDF
Photodynamic Therapy Combined with Bcl-2/Bcl-xL Inhibition Increases the Noxa/Mcl-1 Ratio Independent of Usp9X and Synergistically Enhances Apoptosis in Glioblastoma
2021
·
Carolin Golla
, Mayas Bilal
, et al.
·
Cancers
·
22
PDF
A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen
2020
·
Richard E. Kast
, Alex P. Michael
, et al.
·
Brain Sciences
·
13
PDF
Globus Lucidus: A porcine study of an intracranial implant designed to deliver closed, repetitive photodynamic and photochemical therapy in glioblastoma
2024
·
Nicolas Bader
, Christian Peschmann
, et al.
·
Photodiagnosis and Photodynamic Therapy
·
6
ACTR-44. PRELIMINARY RESULTS FROM THE NCT02770378 PROOF-OF-CONCEPT CLINICAL TRIAL ASSESSING THE SAFETY OF THE CUSP9v3 PROTOCOL COMBINED WITH METRONOMIC TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA
2018
·
Marc-Eric Halatsch
, Richard Kast
, et al.
·
Neuro-Oncology
·
4
PDF
CTNI-04. RECURRENT GLIOBLASTOMA LONG-TERM SURVIVORS TREATED WITH CUSP9v3
2021
·
Marc-Eric Halatsch
, Richard Kast
, et al.
·
Neuro-Oncology
·
3
Rare Case of Sporadic Malignant Optic Pathway Glioma in 71-Year-Old Woman
2019
·
Tim Heiland
, Georg Karpel-Massler
, et al.
·
World Neurosurgery
·
3
Exth-45. the Repurposed Cusp9 Regimen Exerts Potent Anti-neoplastic Activity Against Glioblastoma Cells in Vitro
2018
·
Marc-Eric Halatsch
, Richard Eric Kast
, et al.
·
Neuro-Oncology
PDF
Show more works
View as search
Works count:
20
Citation count:
409
H-index:
8
I10-index:
8
Year
Topic
Type